Latest Cancer News

FDA Approves Use of Xtandi for Chemotherapy Naïve Men With Advanced Prostate Cancer (09-15-2014)
The FDA approved the use of Xtandi® (enzalutamide) in men who have not yet received chemotherapy, significantly expanding the potential patient population eligible to be treated with the oral medicine. ... Continue Reading

New Survey Reveals that Prostate Cancer Impacts Sex Lives More than Any Other Aspect of Patients’ Lives (09-11-2014)
Washington, DC (September 8, 2014) – A recent survey conducted by ZERO – The End of Prostate Cancer and Ferring Pharmaceuticals Inc. aimed to uncover the impact of prostate cancer on patients, their... Continue Reading

Promising Activity of Imbruvica Plus Rituxan in High-Risk CLL (09-10-2014)
Researchers from MD Anderson Cancer Center recently reported in the journal The Lancet Oncology that the combination of Imbruvica® (ibrutinib) and Rituxan® (rituximab) showed promising activity in... Continue Reading

More Cancer News

Locations

Scarborough Office
100 Campus Drive, Suite 108
Scarborough, Maine 04074-9308
(207) 396-7600
Fax (207) 396-7610
Brunswick Office
81 Medical Center Drive
Suite 1300G
Brunswick, ME 04011
(207) 729-1148
Fax (207)729-2789
Biddeford Office
26 West Cole Road
Biddeford, Maine 04005-9407
(207) 282-0448
Fax (207)286-9126
Sanford Office
27 Industrial Avenue
Sanford, ME 04073
(207)490-7777
Fax (207) 490-7779